(ACLS) |
| 0 (0%) 04-14 16:55 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 134.13 |
| Resistance 1: | 114.84 |
| Pivot price: | 100.43 |
| Support 1: | 94.50 |
| Support 2: | 81.93 |
| 52w High: | |
| 52w Low: |
| EPS | 3.800 |
| Book Value | 33.680 |
| PEG Ratio | 0.00 |
| Gross Profit | 12.267 |
| Profit Margin (%) | 14.33 |
| Operating Margin (%) | 15.18 |
| Return on Assets (ttm) | 5.5 |
| Return on Equity (ttm) | 11.7 |
Tue, 14 Apr 2026
Axcelis Technologies (NASDAQ:ACLS) Sets New 1-Year High - Still a Buy? - MarketBeat
Tue, 14 Apr 2026
Daily Slop: 14 Apr 26 - Zach Ertz doesn’t want last year’s ACL injury to be final play of his career - Hogs Haven
Tue, 14 Apr 2026
Tetrous’ demineralized bone fiber knee implants used in successful ACL reconstructions - Today's Medical Developments
Mon, 13 Apr 2026
Iran's Traktor arrives in Jeddah for ACL round of 16 amid war - ESPN
Mon, 13 Apr 2026
Crew striker Wessam Abou Ali will miss rest of 2026 season with ACL tear - The Columbus Dispatch
Mon, 13 Apr 2026
TE Zach Ertz, 35, doesn't want ACL injury from 2025 to be his final play - NFL.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |